healthcare

Febo is a condition management platform that gives you personalized access to manage your medical journey. The healthcare app with personalized reports, stay updated with the latest research and news on your condition, wearables integration, medication reminders and advice from your peers and...

Health insurers are dealing with a complex situation in a market battered by the coronavirus. While the present volatility is bound to give way to stability once normalcy returns to the industry, it is not known what effect the crisis would have on insurance firms in the long term.

The case study selected is from Agency for Healthcare Research and Quality (AHRQ). Lincoln Health Hospital mission and vision statement is to provide efficient, compassionate, high quality and cost-effective health care services for individuals in the community. These core values ensure a...

When it comes to healthcare there will always be ever rising costs that are associated to keep the business afloat. The heads of these organizations are responsible to ensure that all needs have been met and also to keep funds readily available to cover unexpected costs that they may incur. The...

The Impact of Federal Healthcare Policies H. Washington There is no doubt or surprise that healthcare cost is rising. There is no way getting around it. People are not liking the increase, but they know having healthcare insurance is essential. The cost is attributed to the cost of...

What Impact Will Federal Regulations Have Concerning Consumer Costs in the Near Future? Since its inception The Affordable Care Act or the ACA has been said to complete many of the goals it set out to achieve. Research evidence shows that there has been a decrease in the overall medical...

Congressional Budget Office: Options for Reducing the Deficit Elisabeth Morehouse University of Phoenix Operating In Structure...

Total revenues declined 5% year-over-year to $12.68 billion from $13.3 billion in the third quarter of 2018. Segment-wise, Biopharma revenues grew 7% annually to $10.1 billion, while Upjohn revenues dropped 26% to $2.19 billion. Consumer Healthcare revenues were down 55%. Pfizer management...

Merck surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in premarket hours on Tuesday. Worldwide sales rose 15% year-over-year to $12.4 billion, beating estimates of $11.6 billion. Excluding foreign exchange impacts, sales...

Eli Lilly surpassed earnings expectations for the third quarter of 2019 but revenues came in shy of estimates. Total revenue grew 3% year-over-year to $5.47 billion, but fell short of estimates of $5.5 billion. Revenues grew 4% excluding foreign currency impacts. Revenue growth was driven by an...

Abbott Laboratories’ third quarter 2019 earnings came in line with the market’s projections, while sales missed the expectations. The pharma company reported adjusted EPS of $0.84 on sales of $8.08 billion. Wall Street had forecasted Abbott to post earnings of $0.84 on sales of $8.11 billion...

Earnings of Johnson & Johnson increased and topped the Street view in Q3 helped by a 2% growth in sales. Encouraged by the positive outcome, the management revised up its full-year earnings and sales outlook. The company’s stock gained following the announcement. Read More

Bristol-Myers-Squibb announced that Amgen will acquire Celgene’s Otezla business for $13.4 billion in a cash transaction. Bristol-Myers now expects to complete the pending merger with Celgene by the end of 2019. For More:

Here's another good show by Alexion Pharma...! June-quarter financial results surpassed the consensus estimates of Wall Street analysts, powered by flagship SOLIRIS. No doubt, it's a much-needed boost for Alexion. Taking a cue from the impressive results, CEO Ludwig Hantson upgraded the outlook...

Biogen reported second-quarter earnings that surpassed Wall Street expectations. The company reported adjusted earnings of $9.15 per share, way ahead of the street projection of $7.53 per share. On a GAAP basis, earnings grew 88% to $7.85 per share. Revenue grew 8% to $3.62 billion, surpassing...

Novartis on Thursday surprised Wall Street by reporting a year-over-year increase in net earnings in Q2, helped by higher sales and a one-time divestment gain. The company said its earnings grew 14% to $1.34 per share, even as analysts were anticipating a decline. Riding on the strong sales of...

JNJ kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the opening bell. Reported revenue for the quarter barely changed — inching just 0.1% higher — at $20 billion, while net earnings slipped 14% to $3.7 billion. On a diluted basis, earnings...

Hi everyone. I need some advice on what a good referral contract and salary is for a HHC contract. I have seen a few but I am still unsure. Is it a specific amount per referral or do you have to reach a specific number of referrals before your bonus kicks in? Your help would be greatly appreciated.

Los Angeles Health Center Shortens Wait Times A case study implemented by the Northeast Valley Health Corporation (NEVHC) in April 2018 focuses on the feedback they received from patients through the Consumer Assessment of Healthcare Providers and Systems Clinician & Group Survey...

Want to know about the registration process for medical device and also what is the difference between ISO 13485 and FDA 21 CFR Part 820?